Business & Finance This biotech firm has room to run despite surging nearly 500% in past year, Morgan Stanley says
The investment bank upgraded the pharma stock to overweight from equal weight.
By
· April 21, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
The investment bank upgraded the pharma stock to overweight from equal weight.
Like this:
Like Loading...
Related
The famed dealmaker on his latest acquisition.…
By
· April 21, 2026 · 1 min read
Invesco has nine factor approaches to tracking the S&P 500. All but one have beaten the index this year, and…
By
· April 21, 2026 · 1 min read
Top energy traders warn of unprecedented hit to global energy supplies…
By
· April 21, 2026 · 1 min read
Leave a Reply